-
1
-
-
14844297739
-
Chronic hepatitis b virus infection and mortality from non-liver causes: Results from the haimen city cohort study
-
Chen G, Lin W, Shen F, et al. Chronic hepatitis B virus infection and mortality from non-liver causes: results from the Haimen City cohort study. Int J Epidemiol. 2005; 34: 132-137
-
(2005)
Int J Epidemiol
, vol.34
, pp. 132-137
-
-
Chen, G.1
Lin, W.2
Shen, F.3
-
3
-
-
0036239832
-
Hmg-coa reductase inhibitors and the malignant cell: The statin family of drugs as triggers of tumor-specific apoptosis
-
Wong WW, Dimitroulakos J, Minden MD, et al. HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis. Leukemia. 2002; 16: 508-519
-
(2002)
Leukemia
, vol.16
, pp. 508-519
-
-
Wong, W.W.1
Dimitroulakos, J.2
Minden, M.D.3
-
4
-
-
0037062481
-
3-hydroxy-3-methylglutaryl coa reductase inhibitors prevent high glucose-induced proliferation of mesangial cells via modulation of rho gtpase/p21 signaling pathway: Implications for diabetic nephropathy
-
Danesh FR, Sadeghi MM, Amro N, et al. 3-Hydroxy-3-methylglutaryl CoA reductase inhibitors prevent high glucose-induced proliferation of mesangial cells via modulation of Rho GTPase/p21 signaling pathway: implications for diabetic nephropathy. Proc Nat Acad Sci U S A. 2002; 99: 8301-8305
-
(2002)
Proc Nat Acad Sci U S A.
, vol.99
, pp. 8301-8305
-
-
Danesh, F.R.1
Sadeghi, M.M.2
Amro, N.3
-
5
-
-
0141615830
-
3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors decrease fas ligand expression and cytotoxicity in activated human t lymphocytes
-
Blanco-Colio LM, Munoz-Garcia B, Martin-Ventura JL, et al. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors decrease Fas ligand expression and cytotoxicity in activated human T lymphocytes. Circulation. 2003; 23: 1506-1513
-
(2003)
Circulation
, vol.23
, pp. 1506-1513
-
-
Blanco-Colio, L.M.1
Munoz-Garcia, B.2
Martin-Ventura, J.L.3
-
6
-
-
0035572718
-
Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors
-
Takemoto M, Liao JK. Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors. Arterioscl Thrombo Vascul Biol. 2001; 21: 1712-1719
-
(2001)
Arterioscl Thrombo Vascul Biol
, vol.21
, pp. 1712-1719
-
-
Takemoto, M.1
Liao, J.K.2
-
7
-
-
0344406230
-
Comparative effects of lovastatin on mammary and prostate oncogenesis in transgenic mouse models
-
Shibata MA, Kavanaugh C, Shibata E, et al. Comparative effects of lovastatin on mammary and prostate oncogenesis in transgenic mouse models. Carcinogenesis. 2003; 24: 453-459
-
(2003)
Carcinogenesis
, vol.24
, pp. 453-459
-
-
Shibata, M.A.1
Kavanaugh, C.2
Shibata, E.3
-
8
-
-
0033529171
-
Lovastatin-mediated g1 arrest is through inhibition of the proteasome, independent of hydroxymethyl glutaryl-coa reductase
-
Rao S, Porter DC, Chen X, et al. Lovastatin-mediated G1 arrest is through inhibition of the proteasome, independent of hydroxymethyl glutaryl-CoA reductase. Proc Nat Acad Sci U S A. 1999; 96: 7797-7802
-
(1999)
Proc Nat Acad Sci U S A.
, vol.96
, pp. 7797-7802
-
-
Rao, S.1
Porter, D.C.2
Chen, X.3
-
9
-
-
0028034956
-
Effect of simvastatin, an inhibitor of hydroxy-methylglutaryl coenzyme a reductase, on the growth of human ito cells
-
Mallat A, Preaux AM, Blazejewski S, et al. Effect of simvastatin, an inhibitor of hydroxy-methylglutaryl coenzyme A reductase, on the growth of human Ito cells. Hepatology. 1994; 20: 1589-1594
-
(1994)
Hepatology
, vol.20
, pp. 1589-1594
-
-
Mallat, A.1
Preaux, A.M.2
Blazejewski, S.3
-
11
-
-
84863837081
-
Lipid metabolism in cancer
-
Santos CR, Schulze A. Lipid metabolism in cancer. FEBS J. 2012; 279: 2610-2623
-
(2012)
FEBS J.
, vol.279
, pp. 2610-2623
-
-
Santos, C.R.1
Schulze, A.2
-
12
-
-
0842321807
-
Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma
-
El-Serag HB, Tran T, Everhart JE. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology. 2004; 126: 460-468
-
(2004)
Gastroenterology
, vol.126
, pp. 460-468
-
-
El-Serag, H.B.1
Tran, T.2
Everhart, J.E.3
-
14
-
-
77956210076
-
Inhibition of stearoylcoa desaturase activity blocks cell cycle progression and induces programmed cell death in lung cancer cells
-
Hess D, Chisholm JW, Igal RA. Inhibition of stearoylCoA desaturase activity blocks cell cycle progression and induces programmed cell death in lung cancer cells. PLoS One. 2010; 5: e11394
-
(2010)
PLoS One
, vol.5
, pp. e11394
-
-
Hess, D.1
Chisholm, J.W.2
Igal, R.A.3
-
15
-
-
0031053093
-
Lovastatin induction of cyclindependent kinase inhibitors in human breast cells occurs in a cell cycle-independent fashion
-
Gray-Bablin J, Rao S, Keyomarsi K. Lovastatin induction of cyclindependent kinase inhibitors in human breast cells occurs in a cell cycle-independent fashion. Cancer Res. 1997; 57: 604-609
-
(1997)
Cancer Res
, vol.57
, pp. 604-609
-
-
Gray-Bablin, J.1
Rao, S.2
Keyomarsi, K.3
-
16
-
-
0032487933
-
Lovastatin mediated g1 arrest in normal and tumor breast cells is through inhibition of cdk2 activity and redistribution of p21 and p27, independent of p53
-
Rao S, Lowe M, Herliczek TW, et al. Lovastatin mediated G1 arrest in normal and tumor breast cells is through inhibition of CDK2 activity and redistribution of p21 and p27, independent of p53. Oncogene. 1998; 17: 2393-2402
-
(1998)
Oncogene
, vol.17
, pp. 2393-2402
-
-
Rao, S.1
Lowe, M.2
Herliczek, T.W.3
-
17
-
-
39549117982
-
Fatty acid synthase gene is upregulated by hypoxia via activation of akt and sterol regulatory element binding protein-1
-
Furuta E, Pai SK, Zhan R, et al. Fatty acid synthase gene is upregulated by hypoxia via activation of Akt and sterol regulatory element binding protein-1. Cancer Res. 2008; 68: 1003-1011
-
(2008)
Cancer Res
, vol.68
, pp. 1003-1011
-
-
Furuta, E.1
Pai, S.K.2
Zhan, R.3
-
18
-
-
80054078528
-
Statin prescriptions and breast cancer recurrence risk: A danish nationwide prospective cohort study
-
Ahern TP, Pedersen L, Tarp M, et al. Statin prescriptions and breast cancer recurrence risk: a Danish nationwide prospective cohort study. J Nat Cancer Inst. 2011; 103: 1461-1468
-
(2011)
J Nat Cancer Inst
, vol.103
, pp. 1461-1468
-
-
Ahern, T.P.1
Pedersen, L.2
Tarp, M.3
-
19
-
-
78049523865
-
Effect of statin therapy on colorectal cancer
-
Bardou M, Barkun A, Martel M. Effect of statin therapy on colorectal cancer. Gut. 2010; 59: 1572-1585
-
(2010)
Gut
, vol.59
, pp. 1572-1585
-
-
Bardou, M.1
Barkun, A.2
Martel, M.3
-
20
-
-
29944446607
-
Statins and cancer risk: A meta-Analysis
-
Dale KM, Coleman CI, Henyan NN, et al. Statins and cancer risk: a meta-Analysis. JAMA. 2006; 295: 74-80
-
(2006)
JAMA
, vol.295
, pp. 74-80
-
-
Dale, K.M.1
Coleman, C.I.2
Henyan, N.N.3
-
21
-
-
34548019063
-
Statins and the risk of colorectal cancer: A meta-Analysis of 18 studies involving more than 1.5 million patients
-
Bonovas S, Filioussi K, Flordellis CS, et al. Statins and the risk of colorectal cancer: a meta-Analysis of 18 studies involving more than 1.5 million patients. J Clin Oncol. 2007; 25: 3462-3468
-
(2007)
J Clin Oncol
, vol.25
, pp. 3462-3468
-
-
Bonovas, S.1
Filioussi, K.2
Flordellis, C.S.3
-
22
-
-
69549097703
-
New users of metformin are at low risk of incident cancer: A cohort study among people with type 2 diabetes
-
Libby G, Donnelly LA, Donnan PT, et al. New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes. Diabetes Care. 2009; 32: 1620-1625
-
(2009)
Diabetes Care
, vol.32
, pp. 1620-1625
-
-
Libby, G.1
Donnelly, L.A.2
Donnan, P.T.3
-
23
-
-
78649302320
-
Metformin and cancer risk in diabetic patients: A systematic review and meta-Analysis
-
Decensi A, Puntoni M, Goodwin P, et al. Metformin and cancer risk in diabetic patients: a systematic review and meta-Analysis. Cancer Prevent Res. 2010; 3: 1451-1461
-
(2010)
Cancer Prevent Res
, vol.3
, pp. 1451-1461
-
-
Decensi, A.1
Puntoni, M.2
Goodwin, P.3
-
24
-
-
84858695046
-
Cancer risk in diabetic patients treated with metformin: A systematic review and meta-Analysis
-
Noto H, Goto A, Tsujimoto T, et al. Cancer risk in diabetic patients treated with metformin: a systematic review and meta-Analysis. PLoS One. 2012; 7: e33411
-
(2012)
PLoS One
, vol.7
, pp. e33411
-
-
Noto, H.1
Goto, A.2
Tsujimoto, T.3
-
25
-
-
84862064131
-
Statin use as a moderator of metformin effect on risk for prostate cancer among type 2 diabetic patients
-
Lehman DM, Lorenzo C, Hernandez J, et al. Statin use as a moderator of metformin effect on risk for prostate cancer among type 2 diabetic patients. Diabetes Care. 2012; 35: 1002-1007
-
(2012)
Diabetes Care
, vol.35
, pp. 1002-1007
-
-
Lehman, D.M.1
Lorenzo, C.2
Hernandez, J.3
-
26
-
-
84930352654
-
Combination of metformin and statins significantly enhanced the local radio therapeutic effect and attenuated the lung metastasis of lewis lung carcinoma (llc) animal model
-
Wu SY, Lin KC, Chiou JF, et al. Combination of metformin and statins significantly enhanced the local radio therapeutic effect and attenuated the lung metastasis of lewis lung carcinoma (LLC) animal model. Int J Rad Oncol Biol Phys. 2014; 90: S800-S801
-
(2014)
Int J Rad Oncol Biol Phys
, vol.90
, pp. S800-S801
-
-
Wu, S.Y.1
Lin, K.C.2
Chiou, J.F.3
-
27
-
-
84862746989
-
Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 us centers
-
Darwish Murad S, Kim WR, Harnois DM, et al. Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers. Gastroenterology. 2012; 143: 88-98
-
(2012)
Gastroenterology
, vol.143
, pp. 88-98
-
-
Darwish Murad, S.1
Kim, W.R.2
Harnois, D.M.3
-
28
-
-
20444461067
-
Metformin and reduced risk of cancer in diabetic patients
-
Evans JM, Donnelly LA, Emslie-Smith AM, et al. Metformin and reduced risk of cancer in diabetic patients. BMJ. 2005; 330: 1304-1305
-
(2005)
BMJ
, vol.330
, pp. 1304-1305
-
-
Evans, J.M.1
Donnelly, L.A.2
Emslie-Smith, A.M.3
-
29
-
-
67650169923
-
Antidiabetic therapy and increased risk of hepatocellular carcinoma in chronic liver disease
-
Donadon V, Balbi M, Ghersetti M, et al. Antidiabetic therapy and increased risk of hepatocellular carcinoma in chronic liver disease. World J Gastroenterol. 2009; 15: 2506-2511
-
(2009)
World J Gastroenterol
, vol.15
, pp. 2506-2511
-
-
Donadon, V.1
Balbi, M.2
Ghersetti, M.3
-
30
-
-
77954365681
-
Metformin and reduced risk of hepatocellular carcinoma in diabetic patients with chronic liver disease
-
Donadon V, Balbi M, Mas MD, et al. Metformin and reduced risk of hepatocellular carcinoma in diabetic patients with chronic liver disease. Liver Int. 2010; 30: 750-758
-
(2010)
Liver Int
, vol.30
, pp. 750-758
-
-
Donadon, V.1
Balbi, M.2
Mas, M.D.3
-
31
-
-
77951006620
-
Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma
-
Hassan MM, Curley SA, Li D, et al. Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma. Cancer. 2010; 116: 1938-1946
-
(2010)
Cancer
, vol.116
, pp. 1938-1946
-
-
Hassan, M.M.1
Curley, S.A.2
Li, D.3
-
32
-
-
84855432249
-
Risk of hepatocellular carcinoma in diabetic patients and risk reduction associated with antidiabetic therapy: A population-based cohort study
-
Lai SW, Chen PC, Liao KF, et al. Risk of hepatocellular carcinoma in diabetic patients and risk reduction associated with antidiabetic therapy: a population-based cohort study. Am J Gastroenterol. 2012; 107: 46-52
-
(2012)
Am J Gastroenterol
, vol.107
, pp. 46-52
-
-
Lai, S.W.1
Chen, P.C.2
Liao, K.F.3
-
33
-
-
65349175605
-
Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro
-
Alimova IN, Liu B, Fan Z, et al. Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro. Cell cycle. 2009; 8: 909-915
-
(2009)
Cell Cycle
, vol.8
, pp. 909-915
-
-
Alimova, I.N.1
Liu, B.2
Fan, Z.3
-
34
-
-
60749108023
-
The antidiabetic drug metformin suppresses her2 (erbb-2) oncoprotein overexpression via inhibition of the mtor effector p70s6k1 in human breast carcinoma cells
-
Vazquez-Martin A, Oliveras-Ferraros C, Menendez JA. The antidiabetic drug metformin suppresses HER2 (erbB-2) oncoprotein overexpression via inhibition of the mTOR effector p70S6K1 in human breast carcinoma cells. Cell cycle. 2009; 8: 88-96
-
(2009)
Cell Cycle
, vol.8
, pp. 88-96
-
-
Vazquez-Martin, A.1
Oliveras-Ferraros, C.2
Menendez, J.A.3
-
35
-
-
70450021431
-
Mtor inhibitors and the antidiabetic biguanide metformin: New insights into the molecular management of breast cancer resistance to the her2 tyrosine kinase inhibitor lapatinib (tykerb
-
Menendez J.A.
-
Vazquez-Martin A, Oliveras-Ferraros C, del Barco S, et al. Menendez JA. mTOR inhibitors and the antidiabetic biguanide metformin: new insights into the molecular management of breast cancer resistance to the HER2 tyrosine kinase inhibitor lapatinib (Tykerb). Clin Translational Oncol. 2009; 11: 455-459
-
(2009)
Clin Translational Oncol
, vol.11
, pp. 455-459
-
-
Vazquez-Martin, A.1
Oliveras-Ferraros, C.2
Del Barco, S.3
-
37
-
-
1642328617
-
Stimulation of the amp-Activated protein kinase leads to activation of eukaryotic elongation factor 2 kinase and to its phosphorylation at a novel site, serine 398
-
Browne GJ, Finn SG, Proud CG. Stimulation of the AMP-Activated protein kinase leads to activation of eukaryotic elongation factor 2 kinase and to its phosphorylation at a novel site, serine 398. J Biol Chemistry. 2004; 279: 12220-12231
-
(2004)
J Biol Chemistry
, vol.279
, pp. 12220-12231
-
-
Browne, G.J.1
Finn, S.G.2
Proud, C.G.3
-
38
-
-
0034644525
-
Tor, a central controller of cell growth
-
Schmelzle T, Hall MN. TOR, a central controller of cell growth. Cell. 2000; 103: 253-262
-
(2000)
Cell
, vol.103
, pp. 253-262
-
-
Schmelzle, T.1
Hall, M.N.2
-
39
-
-
0345167800
-
Tsc2 mediates cellular energy response to control cell growth and survival
-
Inoki K, Zhu T, Guan KL. TSC2 mediates cellular energy response to control cell growth and survival. Cell. 2003; 115: 577-590
-
(2003)
Cell
, vol.115
, pp. 577-590
-
-
Inoki, K.1
Zhu, T.2
Guan, K.L.3
-
40
-
-
42949139481
-
Ampk phosphorylation of raptor mediates a metabolic checkpoint
-
Gwinn DM, Shackelford DB, Egan DF, et al. AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol Cell. 2008; 30: 214-226
-
(2008)
Mol Cell
, vol.30
, pp. 214-226
-
-
Gwinn, D.M.1
Shackelford, D.B.2
Egan, D.F.3
-
41
-
-
13344270279
-
Diabetes mellitus and breast cancer
-
Wolf I, Sadetzki S, Catane R, et al. Diabetes mellitus and breast cancer. Lancet Oncol. 2005; 6: 103-111
-
(2005)
Lancet Oncol
, vol.6
, pp. 103-111
-
-
Wolf, I.1
Sadetzki, S.2
Catane, R.3
-
42
-
-
21244485747
-
Type-ii diabetes and pancreatic cancer: A meta-Analysis of 36 studies
-
Huxley R, Ansary-Moghaddam A, Berrington de Gonzalez A, et al. Type-II diabetes and pancreatic cancer: a meta-Analysis of 36 studies. Br J Cancer. 2005; 92: 2076-2083
-
(2005)
Br J Cancer
, vol.92
, pp. 2076-2083
-
-
Huxley, R.1
Ansary-Moghaddam, A.2
Berrington De Gonzalez, A.3
-
43
-
-
27944450832
-
Diabetes mellitus and risk of colorectal cancer: A meta-Analysis
-
Larsson SC, Orsini N, Wolk A. Diabetes mellitus and risk of colorectal cancer: a meta-Analysis. J Nat Cancer Inst. 2005; 97: 1679-1687
-
(2005)
J Nat Cancer Inst
, vol.97
, pp. 1679-1687
-
-
Larsson, S.C.1
Orsini, N.2
Wolk, A.3
-
44
-
-
34249948987
-
Diabetes mellitus and risk of endometrial cancer: A meta-Analysis
-
Friberg E, Orsini N, Mantzoros CS, et al. Diabetes mellitus and risk of endometrial cancer: a meta-Analysis. Diabetologia. 2007; 50: 1365-1374
-
(2007)
Diabetologia
, vol.50
, pp. 1365-1374
-
-
Friberg, E.1
Orsini, N.2
Mantzoros, C.S.3
-
45
-
-
68149131125
-
Obesity related hyperinsulinaemia and hyperglycaemia and cancer development
-
Becker S, Dossus L, Kaaks R. Obesity related hyperinsulinaemia and hyperglycaemia and cancer development. Arc Physiol Biochem. 2009; 115: 86-96
-
(2009)
Arc Physiol Biochem
, vol.115
, pp. 86-96
-
-
Becker, S.1
Dossus, L.2
Kaaks, R.3
-
46
-
-
22244446505
-
The mammalian unfolded protein response
-
Schroder M, Kaufman RJ. The mammalian unfolded protein response. Ann Rev Biochem. 2005; 74: 739-789
-
(2005)
Ann Rev Biochem
, vol.74
, pp. 739-789
-
-
Schroder, M.1
Kaufman, R.J.2
-
47
-
-
66249092010
-
Chemical genomics identifies the unfolded protein response as a target for selective cancer cell killing during glucose deprivation
-
Saito S, Furuno A, Sakurai J, et al. Chemical genomics identifies the unfolded protein response as a target for selective cancer cell killing during glucose deprivation. Cancer Res. 2009; 69: 4225-4234
-
(2009)
Cancer Res
, vol.69
, pp. 4225-4234
-
-
Saito, S.1
Furuno, A.2
Sakurai, J.3
-
48
-
-
0020040832
-
Metabolic immunodepression and metabolic immunotherapy: An attempt of improvement in immunologic response in breast cancer patients by correction of metabolic disturbances
-
Dilman VM, Berstein LM, Ostroumova MN, et al. Metabolic immunodepression and metabolic immunotherapy: an attempt of improvement in immunologic response in breast cancer patients by correction of metabolic disturbances. Oncology. 1982; 39: 13-19
-
(1982)
Oncology
, vol.39
, pp. 13-19
-
-
Dilman, V.M.1
Berstein, L.M.2
Ostroumova, M.N.3
-
49
-
-
67650096912
-
Enhancing cd8 t-cell memory by modulating fatty acid metabolism
-
Pearce EL, Walsh MC, Cejas PJ, et al. Enhancing CD8 T-cell memory by modulating fatty acid metabolism. Nature. 2009; 460: 103-107
-
(2009)
Nature
, vol.460
, pp. 103-107
-
-
Pearce, E.L.1
Walsh, M.C.2
Cejas, P.J.3
-
50
-
-
70350236538
-
Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission
-
Hirsch HA, Iliopoulos D, Tsichlis PN, et al. Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission. Cancer Res. 2009; 69: 7507-7511
-
(2009)
Cancer Res
, vol.69
, pp. 7507-7511
-
-
Hirsch, H.A.1
Iliopoulos, D.2
Tsichlis, P.N.3
-
51
-
-
79954460690
-
The anti-diabetic drug metformin suppresses self-renewal and proliferation of trastuzumab-resistant tumor-initiating breast cancer stem cells
-
Vazquez-Martin A, Oliveras-Ferraros C, Del Barco S, et al. The anti-diabetic drug metformin suppresses self-renewal and proliferation of trastuzumab-resistant tumor-initiating breast cancer stem cells. Breast Cancer Res Treat. 2011; 126: 355-364
-
(2011)
Breast Cancer Res Treat
, vol.126
, pp. 355-364
-
-
Vazquez-Martin, A.1
Oliveras-Ferraros, C.2
Del Barco, S.3
-
52
-
-
77957005003
-
Metformin regulates breast cancer stem cell ontogeny by transcriptional regulation of the epithelial-mesenchymal transition (emt) status
-
Vazquez-Martin A, Oliveras-Ferraros C, Cufi S, et al. Metformin regulates breast cancer stem cell ontogeny by transcriptional regulation of the epithelial-mesenchymal transition (EMT) status. Cell Cycle. 2010; 9: 3807-3814
-
(2010)
Cell Cycle
, vol.9
, pp. 3807-3814
-
-
Vazquez-Martin, A.1
Oliveras-Ferraros, C.2
Cufi, S.3
-
53
-
-
43049165453
-
The epithelial-mesenchymal transition generates cells with properties of stem cells
-
Mani SA, Guo W, Liao MJ, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 2008; 133: 704-715
-
(2008)
Cell
, vol.133
, pp. 704-715
-
-
Mani, S.A.1
Guo, W.2
Liao, M.J.3
-
54
-
-
78649872745
-
Metformin against tgfbeta-induced epithelial-To-mesenchymal transition (emt): From cancer stem cells to aging-Associated fibrosis
-
Cufi S, Vazquez-Martin A, Oliveras-Ferraros C, et al. Metformin against TGFbeta-induced epithelial-To-mesenchymal transition (EMT): from cancer stem cells to aging-Associated fibrosis. Cell Cycle. 2010; 9: 4461-4468
-
(2010)
Cell Cycle
, vol.9
, pp. 4461-4468
-
-
Cufi, S.1
Vazquez-Martin, A.2
Oliveras-Ferraros, C.3
-
55
-
-
84863115964
-
Statins and the risk of hepatocellular carcinoma in patients with hepatitis b virus infection
-
Tsan YT, Lee CH, Wang JD, et al. Statins and the risk of hepatocellular carcinoma in patients with hepatitis B virus infection. J Clin Oncol. 2012; 30: 623-630
-
(2012)
J Clin Oncol
, vol.30
, pp. 623-630
-
-
Tsan, Y.T.1
Lee, C.H.2
Wang, J.D.3
-
56
-
-
33745903898
-
Different anti-hcv profiles of statins and their potential for combination therapy with interferon
-
Ikeda M, Abe K, Yamada M, et al. Different anti-HCV profiles of statins and their potential for combination therapy with interferon. Hepatology. 2006; 44: 117-125
-
(2006)
Hepatology
, vol.44
, pp. 117-125
-
-
Ikeda, M.1
Abe, K.2
Yamada, M.3
-
57
-
-
79961218135
-
Increased risk of hepatocellular carcinoma in patients with diabetes mellitus: A systematic review and meta-Analysis of cohort studies
-
Wang C, Wang X, Gong G, et al. Increased risk of hepatocellular carcinoma in patients with diabetes mellitus: a systematic review and meta-Analysis of cohort studies. Int J Cancer. 2012; 130: 1639-1648
-
(2012)
Int J Cancer
, vol.130
, pp. 1639-1648
-
-
Wang, C.1
Wang, X.2
Gong, G.3
-
58
-
-
33749031867
-
Diabetes mellitus and the risk of cancer: Results from a large-scale population-based cohort study in japan
-
Inoue M, Iwasaki M, Otani T, et al. Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. Arc Internal Med. 2006; 166: 1871-1877
-
(2006)
Arc Internal Med
, vol.166
, pp. 1871-1877
-
-
Inoue, M.1
Iwasaki, M.2
Otani, T.3
-
59
-
-
33745556520
-
Type 2 diabetes and hepatocellular carcinoma: A cohort study in high prevalence area of hepatitis virus infection
-
Lai MS, Hsieh MS, Chiu YH, et al. Type 2 diabetes and hepatocellular carcinoma: a cohort study in high prevalence area of hepatitis virus infection. Hepatology. 2006; 43: 1295-1302
-
(2006)
Hepatology
, vol.43
, pp. 1295-1302
-
-
Lai, M.S.1
Hsieh, M.S.2
Chiu, Y.H.3
-
60
-
-
34249880490
-
Diabetes mellitus increases the risk of hepatocarcinogenesis in patients with alcoholic cirrhosis: A preliminary report
-
Torisu Y, Ikeda K, Kobayashi M, et al. Diabetes mellitus increases the risk of hepatocarcinogenesis in patients with alcoholic cirrhosis: a preliminary report. Hepatol Res. 2007; 37: 517-523
-
(2007)
Hepatol Res
, vol.37
, pp. 517-523
-
-
Torisu, Y.1
Ikeda, K.2
Kobayashi, M.3
-
61
-
-
0036219298
-
Diabetes mellitus may be associated with hepatocarcinogenesis in patients with chronic hepatitis C
-
Tazawa J, Maeda M, Nakagawa M, et al. Diabetes mellitus may be associated with hepatocarcinogenesis in patients with chronic hepatitis C. Dig Dis Sci. 2002; 47: 710-715
-
(2002)
Dig Dis Sci
, vol.47
, pp. 710-715
-
-
Tazawa, J.1
Maeda, M.2
Nakagawa, M.3
-
62
-
-
78650710888
-
The relationship between new-onset diabetes mellitus and pancreatic cancer risk: A case-control study
-
Ben Q, Cai Q, Li Z, et al. The relationship between new-onset diabetes mellitus and pancreatic cancer risk: a case-control study. Eur J Cancer. 2011; 47: 248-254
-
(2011)
Eur J Cancer
, vol.47
, pp. 248-254
-
-
Ben, Q.1
Cai, Q.2
Li, Z.3
-
63
-
-
33644759114
-
The association between diabetes and hepatocellular carcinoma: A systematic review of epidemiologic evidence
-
El-Serag HB, Hampel H, Javadi F. The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. Clin Gastroenterol Hepatol. 2006; 4: 369-380
-
(2006)
Clin Gastroenterol Hepatol
, vol.4
, pp. 369-380
-
-
El-Serag, H.B.1
Hampel, H.2
Javadi, F.3
-
64
-
-
67349134980
-
Association of a diabetes risk score with risk of myocardial infarction, stroke, specific types of cancer, and mortality: A prospective study in the european prospective investigation into cancer and nutrition (epic)-potsdam cohort
-
Heidemann C, Boeing H, Pischon T, et al. Association of a diabetes risk score with risk of myocardial infarction, stroke, specific types of cancer, and mortality: a prospective study in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam cohort. Eur J Epidemiol. 2009; 24: 281-288
-
(2009)
Eur J Epidemiol
, vol.24
, pp. 281-288
-
-
Heidemann, C.1
Boeing, H.2
Pischon, T.3
-
65
-
-
40049088464
-
Diabetes and endometrial cancer: An evaluation of the modifying effects of other known risk factors
-
Saltzman BS, Doherty JA, Hill DA, et al. Diabetes and endometrial cancer: an evaluation of the modifying effects of other known risk factors. Am J Epidemiol. 2008; 167: 607-614
-
(2008)
Am J Epidemiol
, vol.167
, pp. 607-614
-
-
Saltzman, B.S.1
Doherty, J.A.2
Hill, D.A.3
|